IDEX reports record Q4 EPS $1.55, full-year EPS $5.88; acquires Nexsight for $120M; guides FY22 adj EPS $7.33-$7.63

IDEX CORP /DE/

2021-FY EPS reported $5.88 revenue$2,764,800,000

Record Q4 EPS $1.55 on sales $714.8M (+16% overall, +11% organic vs Q4 2020); full year EPS $5.88 (+19%).
Full year sales $2.8B (+18%); adjusted EPS $6.30 (+21%); record Q4 orders $795.3M (+17%).
Acquired Nexsight (Envirosight, WinCan, MyTana, Pipeline Renewal Technologies) for $120M cash; expected close Q1 2022.
FY22 guidance: organic sales growth 5-8%; GAAP EPS $6.70-$7.00, adjusted EPS $7.33-$7.63 under revised definition.
Health & Science Technologies led with Q4 sales +25% (+16% organic); segment margin up 210 bps to 25.8%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.